Picture [iito] Life Science Business Portals Media Data 2022 2 650x100px

News > All

Total search results: 6736 | Ordered by Date (descending)
next pagenext page 1 2 3 4 ... 66 67 68  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Evotec SE. (3/21/22). "Press Release: Evotec Receives €3m Milestone Payment for Bayer Starting Phase II Clinical Development of DNP Programme". Hamburg. 2022-03-21
Nagi Bioscience S.A.. (3/21/22). "Press Release: The SERI-funded EIC Accelerator Program Grants Nagi Bioscience with €2.5 Million to Accelerate Development and Commercial Scale-up of Their Unique ‘Organism-on-Chip’ Product". Lausanne. 2022-03-21
Bavarian Nordic A/S. (3/21/22). "Press Release: Bavarian Nordic Announces License and Supply Agreement with Nuance Pharma on the Development and Commercialization of Respiratory Syncytial Virus (RSV) Vaccine for Adults in China and Selected Asian Markets 2022-03-21
BigOmics Analytics S.A.. (3/17/22). "Press Release: BigOmics Closes Pre-Series A with Additional Investment from Eppendorf". Lugano. 2022-03-17
Bruker Corporation. (3/16/22). "Press Release: Bruker Appoints Philip Ma to Its Board of Directors". Billerica, MA. 2022-03-16
Immunic, Inc.. (3/16/22). "Press Release: Immunic, Inc. Announces Promotion of Glenn Whaley, CPA to Chief Financial Officer". New York, NY. 2022-03-16
Gilde Healthcare Partners. (3/16/22). "Press Release: Gilde Healthcare Raises more than €500 Million for Private Equity Investments in European Healthcare Companies". Utrecht. 2022-03-16
InfanDx AG. (3/15/22). "Press Release: Neonatal Diagnostics Company InfanDx AG Closes Oversubscribed Second Tranche of Series A". Cologne & Boston, MA. 2022-03-15
Adrenomed AG. (3/15/22). "Press Release: Adrenomed Supervisory Board Appoints Dr. Richard Jones as CEO". Hennigsdorf. 2022-03-15
Temedica GmbH. (3/15/22). "Press Release: Temedica Announces Cooperation with Bristol Myers Squibb for the Development of a Digital Companion for Psoriasis Patients". Munich. 2022-03-15
Bruker Corporation. (3/15/22). "Press Release: Bruker Leads $46 Million New Financing Round for PrognomiQ to Advance Development of Next-Generation Multi-omics Liquid Biopsy Products for Cancer". San Mateo, CA. 2022-03-15
Ginkgo Bioworks Inc.. (3/14/22). "Press Release: Ginkgo Bioworks Signs Definitive Agreement to Acquire FGen AG, a Leading Bioengineering Company and Its Proprietary Ultra-high-throughput Screening Platform". Boston, MA & Basel. 2022-03-14
Ayoxxa Biosystems GmbH. (3/14/22). "Press Release: Ayoxxa Receives Fresh Capital for Commercial Growth in Europe, US and Asia Led by Prosnav Capital". Cologne. 2022-03-14
Forbion Capital Partners. (3/14/22). "Press Release: Forbion Strengthens Its Team with the Appointments of Mathias Vinther and Vanessa Carle". Naarden. 2022-03-14
MedXCell S.A.. (3/11/22). "Press Release: MedXCell SA Is Proud to Annonce the Arrival of Andrew Galzaka and John D. McMannis as New Members of the Board and Pierre J.Magistretti as New Scientific Advisor". Montreux. 2022-03-11
MorphoSys AG. (3/10/22). "Press Release (Ad hoc): MorphoSys AG Reports Non-cash Impairment Charge of approx. € 231 Million on Goodwill after Consolidation of Research and Discovery Functions, Corresponding Increase of Group Operating Expenses in 2021". P 2022-03-10
Scenic Biotech B.V.. (3/10/22). "Press Release: Scenic Biotech Announces $31 Million Financing to Progress Pipeline of Genetic Modifiers in Cancer and Rare Diseases". Amsterdam. 2022-03-10
Heidelberg Pharma AG. (3/10/22). "Press Release: Heidelberg Pharma Receives Milestone Payment from Partner Magenta for Dosing the First Patient with MGTA-117". Ladenburg. 2022-03-10
Vaximm AG. (3/8/22). "Press Release: NEC OncoImmunity Acquires Vaximm’s Neoantigen Vaccine Development Assets". Oslo, Tokyo, Basel & Mannheim. 2022-03-08
BioNTech SE. (3/8/22). "Press Release: BioNTech and Regeneron Expand Strategic Collaboration to Advance Clinical Development of FixVac and Libtayo (cemiplimab) Combination in NSCLC". Mainz. 2022-03-08
Enzymicals AG. (3/8/22). "Press Release: Enzymicals AG Board of Supervisors Appoints New Management with Dr. Erik de Vries as CEO". Greifswald. 2022-03-08
Solvias AG. (3/8/22). "Press Release: Solvias Appoints Archie Cullen Chief Executive Officer". Kaiseraugst. 2022-03-08
Singleron Biotechnologies. (3/7/22). "Press Release: Singleron Acquires Proteona". Nanjing, Suzhou, Cologne & Singapore. 2022-03-07
Enamine Ltd.. (3/7/22). "Press Release: Open Letter from Enamine Founder and CEO Dr. Andrey Tolmachov". 2022-03-07
LenioBio GmbH. (3/7/22). "Press Release: LenioBio Closes Its Series-A Extension Round and Strengthens Its Board of Directors". Düsseldorf. 2022-03-07
Kurma Partners. (3/7/22). "Press Release: Kurma Partners Targets €250 Million for its First Growth Opportunities Fund". Paris. 2022-03-07
InxMed Co., Ltd.. (3/4/22). "Press Release: InxMed Raised $50 Million in Series B Financing to Advance Innovative Therapies to Drug-resistance Cancers". Nanjing. 2022-03-04
ArrePath. (3/3/22). "Press Release: ArrePath Announces $20 Million Seed Financing to Advance its Machine Learning-based Platform for Discovery of Novel Anti-infectives Addressing Antimicrobial Resistance". Princeton, NJ. 2022-03-03
Epsilogen Ltd.. (3/2/22). "Press Release: Epsilogen Announces Completion of Oversubscribed £30.75 Million ($41.20 Million) Series B Financing". London. 2022-03-02
Ampersand Capital Partners. (3/1/22). "Press Release: BioEcho Life Sciences Receives Growth Equity Investment from Ampersand Capital Partners". Cologne. 2022-03-01
CureVac N.V.. (3/1/22). "Press Release: CureVac Establishes Fully-Owned Company Dedicated to Advancing The RNA Printer". Tübingen & Boston, MA. 2022-03-01
ECBF Management GmbH. (3/1/22). "Press Release: €34M to End Chick Culling. Impact Fund ECBF Invests In AgTech In Ovo". Luxembourg. 2022-03-01
EQT AB. (3/1/22). "Press Release: EQT Closes Acquisition of LSP and Introduces EQT Life Sciences". 2022-03-01
Heidelberg Pharma AG. (2/28/22). "Press Release: Heidelberg Pharma and Huadong Announce Strategic Partnership, Including Equity Investment". Ladenburg. 2022-02-28
Editas Medicine, Inc.. (2/28/22). "Press Release: Editas Medicine Announces Favorable Decision from U.S. Patent and Trademark Office in CRISPR Patent Interference". Cambridge, MA. 2022-02-28
Evolva Holding S.A.. (2/28/22). "Press Release: Carsten Däweritz Remains CFO of Evolva". Reinach. 2022-02-28
Medigene AG. (2/25/22). "Press Release: Dr. Selwyn Ho Appointed New CEO of Medigene". Lisbon. 2022-02-25
Celeris Therapeutics GmbH. (2/24/22). "Press Release: CelerisTx Appoints Pharmaceuticals Industry Leader Peter Ho, M.D., Ph.D., to the Board of Directors". Menlo Park, CA. 2022-02-24
ECBF Management GmbH. (2/23/22). "Press Release: Growth Capital for Sustainable Transformation to a Bio-based Circular Economy. EU-initiated Impact Fund Oversubscribed with € 300 million". Luxembourg. 2022-02-23
Poseida Therapeutics, Inc.. (2/22/22). "Press Release: Poseida Therapeutics Appoints Brent Warner as President, Gene Therapy". San Diego, CA. 2022-02-22
FZI Forschungszentrum Informatik. (2/21/22). "Press Release: Busy Bees in Search of Data. OCELI Project Makes Causes of Bee Mortality Measurable". Karlsruhe. 2022-02-21
Valneva S.E.. (2/21/22). "Press Release: Valneva Awarded Up to £20 Million by Scottish Enterprise to Advance Vaccine Development". Saint-Herblain. 2022-02-21
BioNTech SE. (2/21/22). "Press Release: BioNTech and Medigene Announce Global Collaboration to Advance T Cell Receptor Immunotherapies Against Cancer". Mainz & Martinsried. 2022-02-21
Vibalogics GmbH. (2/18/22). "Press Release: Vibalogics Acquired by Top Global CDMO Recipharm AB". 2022-02-18
Jeito Capital. (2/17/22). "Press Release: Jeito Capital Announces the Appointments of Dr Andreas Wallnöfer as Partner Investor and Isabelle Meyrier as Head of Legal". Paris. 2022-02-17
Heidelberg Pharma AG. (2/17/22). "Press Release: Heidelberg Pharma AG Secures Financing Commitment From its Main Shareholder dievini (ad hoc)". Ladenburg. 2022-02-17
SpliceBio S.L.. (2/16/22). "Press Release: SpliceBio Raises EUR 50M in Oversubscribed Series A financing to Advance Protein Splicing Platform and Expand Gene Therapy Pipeline". Barcelona. 2022-02-16
Climedo Health GmbH. (2/16/22). "Press Release: Climedo Closes €5 Million Seed Financing Round". Munich. 2022-02-16
ITM Isotope Technologies Munich SE. (2/16/22). "Press Release: ITM Receives Equity Investment of EUR 25 Million from Strategic Partner Grand Pharma". Garching & Hong Kong. 2022-02-16
Centauri Therapeutics Ltd.. (2/16/22). "Press Release: Centauri Therapeutics Closes £24 million GBP Series A Investment Round". London. 2022-02-16
XO Life GmbH. (2/16/22). "Press Release: Two Million Euros for XO Life GmbH’s Patient Insights Platform". Berlin & Munich. 2022-02-16
SHS Gesellschaft für Beteiligungsmanagement mbH. (2/15/22). "Press Release: SHS Sells Leading Enzyme Engineering Company c-LEcta GmbH to Kerry Group". Tübingen. 2022-02-15
Marinomed Biotech AG. (2/15/22). "Press Release: Marinomed Receives €6m with Final Tranche of Financing Agreement with EIB to Invest in Proprietary R&D Pipeline". Korneuburg. 2022-02-15
Kerry Group plc. (2/15/22). "Press Release: Kerry Announces Significant Strategic Biotechnology Acquisitions". 2022-02-15
NMD Pharma A/S. (2/15/22). "Press Release: NMD Pharma Raises €35 Million in a New Financing". Aarhus. 2022-02-15
c-LEcta GmbH. (2/15/22). "Press Release: c-LEcta Announces that it Has Reached Agreement to Be Acquired by Kerry Group". 2022-02-15
IMIdomics, Inc.. (2/15/22). "Press Release: IMIDomics, Inc. Announces Strategic Investment from Drug Discovery and Research Leader Evotec SE". San Rafael, CA & Barcelona. 2022-02-15
ProBioGen AG. (2/11/22). "Press Release: ProBioGen Signs a Commercial License Agreement with AstraZeneca Providing their GlymaxX® Technology". Berlin. 2022-02-11
Green Elephant Biotech GmbH. (2/11/22). "Press Release: Pre-seed Funding Round for Green Elephant Biotech. BMH Invests in Developer of Sustainable Cell Cultivation Systems". Wiesbaden & Gießen. 2022-02-11
Celeris Therapeutics GmbH. (2/10/22). "Press Release: CelerisTx Announces $4.4m Financing to Advance Pipeline of Novel Proximity Inducing Compound". Menlo Park, CA. 2022-02-10
Haya Therapeutics S.A.. (2/9/22). "Press Release: Haya Therapeutics Establishes U.S. Location. Haya Closes US$5M Seed Extension". Lausanne & San Diego, CA. 2022-02-09
Lindis Blood Care GmbH. (2/9/22). "Press Release: Lindis Blood Care Successfully Closes Follow-on Financing Round". Hennigsdorf. 2022-02-09
AiCuris Anti-infective Cures AG. (2/9/22). "Press Release: AiCuris and Hybridize Therapeutics Enter Worldwide License Agreement of up to €100M for a Direct-acting RNA-based Therapy against BK Virus". Wuppertal & Leiden. 2022-02-09
Celeris Therapeutics GmbH. (2/9/22). "Press Release: CelerisTx in Artificial Intelligence Research Collaboration with Merck KGaA, Darmstadt, Germany on AI-enabled Degrader Discovery". Menlo Park, CA. 2022-02-09
ECBF Management GmbH. (2/9/22). "Press Release: Insect Scale-up Protix Raises 50 Million for Expansion and Development from International Investors". Wuppertal & Leiden. 2022-02-09
BRAIN Biotech AG. (2/8/22). "Press Release: BRAIN Biotech and Formo. Strategic Partnership of European Biotech Experts for the Production of Animal-free Milk Protein". Zwingenberg. 2022-02-08
Inova Software S.A.S.. (2/8/22). "Press Release: Inova Acquires In-Part, Matchmaking Platform for Academia-Industry Collaboration". Lyon. 2022-02-08
Evolva Holding S.A.. (2/8/22). "Press Release: Evolva Appoints Christian Wichert as New CEO to Boost Growth Strategy and Enter Its Next Phase of Development and Commercialization". Reinach. 2022-02-08
ECBF Management GmbH. (2/7/22). "Press Release: ECBF Invests in the €16M VC Round of Elicit Plant, France, to Accelerate Commercialization of Their Water Stress Management Solutions for Field Crops Internationally". Luxembourg. 2022-02-07
Merck KGaA. (2/7/22). "Press Release: Merck Announces Organizational Transformation of Life Science Business Sector to Strengthen CDMO Offering and Accelerate Future Growth". Darmstadt. 2022-02-07
AMR Action Fund. (2/7/22). "Press Release: AMR Action Fund Opens European Office". Boston, MA. 2022-02-07
Bayer AG. (2/4/22). "Press Release: Bayer Will Discontinue Phase II Development Candidate eliapixant [only for specialized press]". Berlin. 2022-02-04
Evotec SE. (2/4/22). "Press Release: Bayer Discontinues Clinical Development Candidate Eliapixant (BAY1817080), Evotec Regains the Rights to All P2X3 Assets [Ad hoc release]". Hamburg. 2022-02-04
iOmx Therapeutics AG. (2/3/22). "Press Release: iOmx Therapeutics Appoints Dr. Murray Yule as CMO to Lead Clinical Development". Martinsried. 2022-02-03
eTheRNA Immunotherapeutics N.V.. (2/3/22). "Press Release: eTheRNA Announces Research Agreement with Merck to Access mRNA technologies". Niel. 2022-02-03
Nemis Technologies AG. (2/3/22). "Press Release: Nemis Technologies AG Closes a CHF 7.75 Million Series A Funding Round". Dübendorf. 2022-02-03
Bayer AG. (2/3/22). "Press Release: Bayer Appoints Christine Roth as New Head of Oncology Strategic Business Unit at Pharmaceuticals Division". Berlin. 2022-02-03
BRAIN Biotech AG. (2/2/22). "Press Release: AnalytiCon Discovery and Pharvaris Extend Their Collaboration". Potsdam. 2022-02-02
Celeris Therapeutics GmbH. (2/2/22). "Press Release: Celeris Therapeutics, the PIC Engineering Company, Announces the Appointment of Biotech Veterans to Lead Drug Discovery and Biology Efforts". 2022-02-02
Brainomix Ltd.. (2/1/22). "Press Release: Brainomix Announces New Partnership with Boehringer Ingelheim to Develop AI-powered Radiomic Software for Automated Assessment of Solid Tumor Cancer". Oxford. 2022-02-01
HH2E AG. (2/1/22). "Press Release: HH2E, New Strong Player in the German Green Energy Sector. HH2E Plans Investments of €2.7 Billion (CAPEX) in Projects in Germany". 2022-02-01
Medix Biochemica Oy. (2/1/22). "Press Release: Medix Biochemica Expands Its Molecular Diagnostics Business through the Acquisition of myPOLS Biotec". Espoo. 2022-02-01
Centogene N.V.. (2/1/22). "Press Release: Centogene Announces Nomination of Kim Stratton as Chief Executive Officer". Cambridge, MA, Rostock & Berlin. 2022-02-01
Zetta Genomics Ltd.. (2/1/22). "Press Release (News): Zetta Genomics Gains £2.5m Seed Funding to Realise the Power of Genomic Data in Precision Medicine". New York, NY. 2022-02-01
BRAIN Biotech AG. (2/1/22). "Press Release: BRAIN Group Significantly Expands Its Food Enzyme Business with the Acquisition of Breatec B.V. and Comix Business". Zwingenberg. 2022-02-01
Temedica GmbH. (2/1/22). "Press Release: Temedica Partners with Noventi to Enhance Permea-generated Insights to Improve Patient Care". Munich. 2022-02-01
Centogene N.V.. (2/1/22). "Press Release: Centogene Announces USD 62 Million Aggregate Equity and Debt Financings to Support Growth Plan". Cambridge, MA, Rostock & Berlin. 2022-02-01
Roche. (2/1/22). "Press Release: Changes to the Roche Board of Directors and the Corporate Executive Committee". Basel. 2022-02-01
Ethris GmbH. (2/1/22). "Press Release: Ethris Raises $26.3 Million Series B to Advance Pipeline of mRNA-based Therapeutics for Respiratory Diseases". Munich. 2022-02-01
Gandeeva Therapeutics, Inc.. (1/31/22). "Press Release: Gandeeva Raises $40M in Series A Funding to Develop Novel Therapies Based on Precision Imaging of Protein-Drug Interactions". Vancouver, BC. 2022-01-31
Leo Pharma A/S. (1/31/22). "Press Release: Leo Pharma Appoints Christophe Bourdon as New CEO". Ballerup. 2022-01-31
Glooko, Inc.. (1/31/22). "Press Release: Glooko Acquires Germany-Based xbird, a Medical AI Company". Berlin & Palo Alto, CA. 2022-01-31
Ribbon Biolabs GmbH. (1/31/22). "Press Release: Ribbon Biolabs Raises EUR 18 Million Series A Financing Enabling Commercial Scale Production Facilities and US Expansion for DNA Synthesis Technology". Vienna. 2022-01-31
Mainz Biomed N.V.. (1/28/22). "Press Release: Mainz Biomed Announces the Closing of its $25.8 Million Public Follow-on Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares". Berkeley, CA & Mainz. 2022-01-28
Mainz Biomed N.V.. (1/27/22). "Press Release: Mainz Biomed Appoints Steve Quinn as VP Business Development". Berkeley & Mainz. 2022-01-27
Genezen, Inc.. (1/26/22). "Press Release: Genezen Appoints Senior Director of Business Development". 2022-01-26
Cellino Biotech, Inc.. (1/25/22). "Press Release: Leaps by Bayer Leads $80M Series A Financing for Cellino Biotech to Autonomize Stem Cell Therapy Manufacturing". Cambridge, MA & Leverkusen. 2022-01-25
Cytovation AS. (1/25/22). "Press Release: Cytovation Raises $20 Million in Series A Financing Round to Advance Clinical Development of CyPep-1, a First-in-Class Targeted Tumor Membrane Immunotherapy". Bergen. 2022-01-25
InstaDeep. (1/25/22). "Press Release: InstaDeep Raises $100M to Scale Decision-Making AI Products that Solve Real-World Problems". London. 2022-01-25
genOway S.A.. (1/25/22). "Press Release: genOway Grants the Leading UK Academic Research Funder a Non-exclusive License for CRISPR/Cas9 Technology". Lyon. 2022-01-25
next pagenext page 1 2 3 4 ... 66 67 68  next pagenext page


Picture [iito] Fighting Customers 650x100px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at (European life sciences) and (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture [iito] [LSE] Business Portal 650x300px

» top